The members of CANet’s Board of Directors, Committees and Administrative Centre come from across Canada and bring a diverse range of professional, health and leadership expertise.
Dr. Pierre Boyle (Board Chair)
Retired Professor and Vice-Dean (Research), Faculté de médicine, Université de Montréal
Richard Alvarez
CEO, Richard Alvarez & Associates
Dr. John Capone
Vice President Research, Western University
Dr. Shurjeel Choudhri
Senior Vice President & Head of Medical and Scientific Affairs, Bayer Inc.
Krista Connell
CEO, Nova Scotia Health Research Foundation
Vincent Dumez
Co-directeur, Centre d’Excellence sur le Partenariat avec les Patients et le Public, Université de Montréal
Neil Fraser
President, Medtronic Canada
Mr. François Labonté
Senior Finance Executive, Consultant
Dr. Paul Morley
Founder and Chief Science Officer, Zelos Therapeutics
Dr. François Philippon
Head of the Cardiology, Université Laval
Pam Ramsay
Provincial Director, Stroke Services BC
Dr. Anthony Tang
Scientific Director and CEO, CANet
Dr. Katherine Allan (Observer)
Research Associate (Cardiology), St. Michael’s Hospital
Dr. Bryce Pickard (Observer)
Managing Director and COO, CANet
Dr. George Wells (Observer)
Associate Scientific Director, CANet
Dr. Allan Skanes
Atrial Fibrillation
Dr. L. Brent Mitchell
Sudden Cardiac Death
Dr. Robert Sheldon
Syncope
Dr. Anthony Tang (Chair)
Scientific Director and CEO, CANet
Dr. Katherine Allan
Research Associate (Cardiology), St. Michael’s Hospital
Dr. Martin Gardner
Professor, Dalhousie University
Dr. Rafik Goubran
Vice President Research & International, Carleton University
Dr. L. Brent Mitchell
Track Captain (Sudden Cardiac Death ), CANet
Dr. Bryce Pickard
Managing Director and COO, CANet
Dr. Robert Sheldon
Track Captain (Syncope), CANet
Dr. Allan Skanes
Track Captain (Atrial Fibrillation), CANet
Dr. William Stevenson
Professor of Medicine, Brigham and Women’s Hospital
Dr. Mario Talajic
Cardiologist, Institut de Cardiologie de Montréal
Dr. George Wells
Associate Scientific Director, CANet
Hugh Winsor (Patient Partner)
Dr. George Wyse
Professor Emeritus, University of Calgary
Mary Runte (Chair)
Associate Professor, University of Lethbridge
Darrin Bauer
Patient Partner
Sylvain Bédard
Patient Coordinator, Centre of Excellence on Partnership with Patients and the Public
Stephen Blais (Patient Partner)
Ottawa City Councillor
Guillaume Dumais-Levesque (Patient Partner)
Vincent Dumez
Co-directeur, Centre d’Excellence sur le Partenariat avec les Patients et le Public, Université de Montréal
Michael Gilbert (Patient Partner)
President, Synergiq Solutions
Patient Partner
Alison Headland (Patient Partner)
Dr. Bryce Pickard
Managing Director and COO, CANet
Dr. Natalie Szudy
Director, Partnerships and Knowledge Mobilization Manager
Dr. Anthony Tang
Scientific Director and CEO, CANet
Hugh Winsor (Patient Partner)
Caroline Wong
Executive Manager, Centre of Excellence on Partnership with Patients and the Public
Dr. Martin Gardner (Chair)
Professor, Dalhousie University
Dr. Katherine Allan
Research Associate (Cardiology), St. Michael’s Hospital
Guillaume Dumais-Levesque (Patient Partner)
Mary Greene
Director Field Clinical Affairs Canada, St. Jude Medical
Heather Jackson
Provincial Clinical Director, Cardiac Services BC
Dr. William McIntyre
Cardiologist, McMaster University
Dr. Kevin O’Neil
Director of Research, CANet
Pam Ramsay
Provincial Directo, Stroke Services BC
Dr. Anthony Tang
Scientific Director and CEO, CANet
Patricia Theoret-Patrick
Project Manager, University of Ottawa Heart Institute
Dr. Anthony Tang
Scientific Director and CEO
Dr. George Wells
Associate Scientific Director
Dr. Bryce Pickard
Managing Director and COO
Dr. Kevin O’Neil
Director of Research and Training
Fabian A. Folias
Director, Digital Marketing and Communications
Dr. Natalie Szudy
Director, Partnerships and Knowledge Mobilization Manager
Dr. Dimitri Popolov
Research Data and Systems Manager
David Brazier
Accounting and Contracts Manager
Sabrina Wall
Executive Assistant
CANet continues to move aggressively towards the achievement of the goals outlined in our Strategic Plan and to position Canada not only as the leader in arrhythmia research and patient engagement but as a world leader at the forefront of the healthcare sector.
